Winton Group’s AN2 Therapeutics ANTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$85.9K Buy
+16,150
New +$85.5K ﹤0.01% 1042

Other funds holding ANTX

Winton Group's ANTX Position: Q3 2026 in Review

Winton Group opened a new position in AN2 Therapeutics (ANTX) in Q3 2026: 16,150 shares worth $85.9K. The stake represents ﹤0.01% of the portfolio and ranks #1042 among its holdings.

84 funds tracked by Wall St. Rank hold ANTX as of Q3 2026.

  • Winton Group held 16,150 shares of AN2 Therapeutics worth $85.9K as of Q3 2026.
  • AN2 Therapeutics was a new Winton Group position in Q3 2026.
  • AN2 Therapeutics made up ﹤0.01% of Winton Group's portfolio in Q3 2026, its #1042 holding.
  • 84 funds tracked by Wall St. Rank held AN2 Therapeutics as of Q3 2026.

Based on Winton Group's 13F filing for Q3 2026, filed 12 Nov 2026.